[{"id":"ce3343fa-10fb-4d25-ac60-a52a8f5d035a","acronym":"","url":"https://clinicaltrials.gov/study/NCT05374915","created_at":"2022-05-16T12:54:38.932Z","updated_at":"2024-07-02T16:35:04.494Z","phase":"Phase 2","brief_title":"Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)","source_id_and_acronym":"NCT05374915","lead_sponsor":"Kintara Therapeutics, Inc.","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive • HR positive • HER-2 negative • HR positive + HER-2 negative • PTEN mutation + HR positive","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • HR positive • HER-2 negative • HR positive + HER-2 negative • PTEN mutation + HR positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e REM-001 therapy"],"overall_status":"Recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 02/12/2024","start_date":" 02/12/2024","primary_txt":" Primary completion: 12/30/2024","primary_completion_date":" 12/30/2024","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-05-10"}]